Clinical Challenges: Monitoring Cardiotoxicity From Cancer Treatment
MedPage Today,
Clinical Challenges > ACC: Cardiomyopathy Uncertainties remain for when and how to check biomarkers by Nicole Lou, Staff Writer…
Clinical Challenges > ACC: Cardiomyopathy Uncertainties remain for when and how to check biomarkers by Nicole Lou, Staff Writer…
For women with HER2-positive early breast cancer treated with an anthracycline-based regimen followed by trastuzumab (Herceptin)…
June 06, 2021 2 min read Source/Disclosures Published by: Source: Munster PN, et al.
Cardiac dysfunction is a prominent concern in patients receiving therapy for breast cancer, especially those with HER2-positive…
1. In this randomized, placebo controlled study of HER2-positive breast cancer patients receiving trastuzumab, use of…
NEW YORK (Reuters Health) - ACE inhibitors or beta blockers can preserve cardiac function and avoid chemotherapy disruption in…